Study design
brain injury, aneurysmal Subarachnoid Hemorrhage
ANEURYSMAL SUBARACHNOID HEMORRHAGE
The CompLement C5 Antibodies for decreasing brain injury after aneurysmal Subarachnoid Hemorrhage (CLASH) study is an investigator-initiated randomized, open-label phase 2a trial with blinded-outcome assessment in a tertiary referral center in the Netherlands. The study protocol has been published elsewhere.